Phase 2 study of LBH589 for the treatment of Hodgkin lymphoma - ONA
Links shared publicly online about this topic.
- 672total visits
Phase 2 study of LBH589 for the treatment of Hodgkin lymphoma - ONA
View full resource at oncologynurseadvisor.com
Tags: Cancer, Lymphoma, Hodgkin Lymphoma, Stem Cell, Phase 2 Clinical Trial, Novartis
Most Recently Shared on December 7, 2010 at 10:39 pm By:
Phase 2 study of LBH589 for the treatment of Hodgkin lymphoma http://goo.gl/fb/OPM7t
Phase 2 Study of Inotuzumab Ozogamicin for NHL - MPR
empr.com — “Pfizer announced results from its Phase 2 study of inotuzumab ozogamicin for the treatment of B-cell Non-Hodgkin Lymphoma (NHL).” View full resource at empr.com
Most Recently Shared on June 23, 2011 at 3:18 pm By:
MPR News: Phase 2 Study of Inotuzumab Ozogamicin for NHL: Pfizer announced results from its Phase 2 study of ino... http://bit.ly/jN9YPO
Phase 2 Study of PLX3397 for Hodgkin Lymphoma - MPR
empr.com — “Plexxikon announced that it has treated the first patient from its Phase 2 study of PLX3397 for the treatment of Hodgkin lymphoma.” View full resource at empr.com
Most Recently Shared on March 8, 2011 at 4:46 pm By:
MPR News: Phase 2 Study of PLX3397 for Hodgkin Lymphoma: Plexxikon announced that it has treated the first patie... http://bit.ly/h01UzR
Phase 2 study of Revlimid for the treatment of non-Hodgkin's lymphoma (NHL) - MPR
empr.com — “Celgene announced Phase 2 clinical data results from two investigational studies evaluating the combination of Revlimid (lenalidomide) plus Rituxan (rituximab, from Genentech) for the treatment of indolent non-Hodgkin's lymphoma (NHL).” View full resource at empr.com
Most Recently Shared on December 15, 2010 at 7:51 pm By:
MPR News: Phase 2 study of Revlimid for the treatment of non-Hodgkin's lymphoma (NHL): Celgene announced Phase 2... http://bit.ly/i073IC
Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) - MPR
empr.com — “Spectrum Pharmaceuticals announced results from both a Phase 2 and Phase 3 study of Zevalin (ibritumomab tiuxetan) injection for the treatment of follicular non-Hodgkin's lymphoma (NHL).” View full resource at empr.com
Most Recently Shared on December 7, 2010 at 9:12 pm By:
MPR News: Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL): Spectrum Pharmaceu... http://bit.ly/hPNeyO
Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study -- Friedberg et al. 26 (2): 204 -- Journal of Clinical Oncology
jco.ascopubs.org — “Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study -- Friedberg et al. 26 (2): 204 -- Journal of Clinical Oncology” View full resource at jco.ascopubs.org
Most Recently Shared on September 29, 2009 at 4:10 pm By:
Emerging treatments for indolent lymphoma http://bit.ly/17omZT Bendamustine, investigational drug: http://bit.ly/N8BqO
Advertisement
